In a large cohort, we hypothesize that plasma levels of soluble RAGE (sRAGE), GRP78, and VEGF-A, three markers of pathways activated by primary inflammation, may be associated with worse outcomes for COVID-19 ICU patients, and thus may be used as reliable prognostic biomarkers. The gene discussed is AGER; the disease is COVID-19.